A collaboration of researchers in Switzerland, Germany, and the US tracked cardiac function in recreational marathon runners ...

FDA approved CYTK's Myqorzo for oHCM. It reduces heart's pumping ability, has a warning for heart failure and expected to ...

The FDA has approved Myqorzo for the treatment of adults with symptomatic oHCM to improve functional capacity and symptoms.

Final Decision from European Commission Expected in Q1 2026SOUTH SAN FRANCISCO, Calif., (GLOBE NEWSWIRE) -- Cytokinetics, ...

Snow shoveling creates hidden heart strain similar to cardiac stress tests. Learn safer techniques and warning signs to ...

Patrick's scan showed "significant blockages" in his arteries, Murray said. He was at high risk for a dangerous cardiac event ...

Scientists have developed a simple blood test that can predict which heart disease patients face the greatest risk of ...

New research suggests that regular aerobic exercise doesn’t just benefit the heart muscle, but subtly rewires the nerves that control how the heart works. Regular physical activity does more than ...

David C Gaze A marathon pushes the human body close to its limits. Legs tire, lungs burn, and the heart works hard for hours ...

A marathon pushes the human body close to its limits. Legs tire, lungs burn and the heart works hard for hours on end. For years, that strain has raised an uncomfortable question: does running 26 ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCMFDA Approval Based on ...